KMD BIO
- Biotech or pharma, therapeutic R&D
KMD Bio is pioneering a new generation of targeted cancer therapy through its innovative Antibody Conjugated Nano Particle (ACNP) platform. This technology enables precise delivery of potent anticancer agents directly to tumor cells, overcoming limitations of conventional treatments and offering the potential for enhanced efficacy and reduced toxicity
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}